Safety profile of thrombolytic drugs.
Department of Cardiovascular Disease, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
A P
AP
Maggioni
C
C
Fresco
D002543:Cerebral Hemorrhage / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000209:etiology; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006342:Heart Rupture, Post-Infarction / Q000188:drug therapy; D006801:Humans; D007022:Hypotension / Q000209:etiology; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012307:Risk Factors; D015912:Thrombolytic Therapy; D013997:Time Factors
D005343:Fibrinolytic Agents